[Therapeutic consequences of immunologic reactions in manifest tetanus].
D000937:Antigen-Antibody Reactions; D001803:Blood Transfusion; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008214:Lymphocytes; D008231:Lymphopenia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D013742:Tetanus / Q000150:complications / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy; D013743:Tetanus Antitoxin / Q000008:administration & dosage / Q000627:therapeutic use; D013745:Tetanus Toxoid / Q000008:administration & dosage / Q000627:therapeutic use; D014374:Tuberculin Test; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use
D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid; D005719:gamma-Globulins
Therapeutische Konsequenzen aus den immunologischen Reaktionen bei manifestem Tetanus.